开能健康(300272) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was ¥381,392,081.33, representing a 2.51% increase compared to ¥372,040,366.05 in the same period last year[5]. - Net profit attributable to shareholders increased by 34.24% to ¥22,291,406.17 from ¥16,605,727.28 year-on-year[5]. - The company's net profit for Q1 2024 reached CNY 29,349,537.72, a significant increase from CNY 17,525,658.71 in Q1 2023, representing a growth of approximately 67.5%[29]. - Operating profit for the quarter was CNY 34,728,645.25, compared to CNY 21,190,200.16 in the same period last year, indicating a year-over-year increase of about 63.5%[29]. - The total comprehensive income for the quarter was CNY 28,492,833.64, compared to CNY 16,760,127.96 in the same quarter last year, reflecting a growth of approximately 70.5%[30]. - Basic earnings per share rose by 32.09% to ¥0.0391 from ¥0.0296 in the same period last year[5]. - Basic earnings per share increased to CNY 0.0391 from CNY 0.0296, marking a rise of about 32.5%[30]. Cash Flow and Assets - The net cash flow from operating activities was ¥55,098,547.27, up 3.89% from ¥53,035,355.56 in the previous year[5]. - The company reported a net cash flow from operating activities of CNY 55,098,547.27, up from CNY 53,035,355.56 in Q1 2023[32]. - Cash and cash equivalents at the end of the period were CNY 895,586,114.69, slightly up from CNY 894,882,934.24[23]. - Cash and cash equivalents at the end of the period totaled CNY 879,555,440.79, up from CNY 510,020,185.54 at the end of Q1 2023[33]. - The cash and cash equivalents net increase was ¥3,650,181.17, a decrease of 96.68% compared to the previous year[11]. - Total assets at the end of the reporting period were ¥2,997,098,464.46, a slight decrease of 0.04% from ¥2,998,215,755.16 at the end of the previous year[5]. - Total assets amounted to CNY 2,997,098,464.46, a slight decrease from CNY 2,998,215,755.16[25]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 22,931[13]. - The company’s major shareholder, Qu Jianguo, holds 145,978,657 shares, which are subject to a lock-up period[17]. - The company’s top ten shareholders include Qu Jianguo and the Shanghai Jianguo Social Public Welfare Foundation, holding significant stakes[14]. - The company’s total share capital includes a significant portion held by the employee stock ownership plan, reflecting its commitment to employee engagement[18]. Share Repurchase and Bonds - The company completed the repurchase of 10,370,000 shares at a price of RMB 4.31 per share, with a lock-up period from December 21, 2023, to December 20, 2024[18]. - As of the announcement date, the company repurchased a total of 7.0574 million shares, accounting for 1.2227% of the total share capital, with a total expenditure of RMB 29.0567 million[19]. - The company plans to use between RMB 25 million and RMB 50 million for further share repurchases, with a maximum repurchase price of RMB 6 per share[18]. - The company’s employee stock ownership plan was approved on December 6, 2023, and involves the transfer of repurchased shares[18]. - The company’s convertible bonds, "Kaineng Convertible Bonds," had their conversion price adjusted from RMB 5.67 to RMB 5.62 per share, effective from January 24, 2024[20]. - From January 26 to March 31, 2024, a total of 3,999 shares were converted from the "Kaineng Convertible Bonds," with an outstanding bond value of RMB 249.9755 million remaining[22]. - The company’s stock has been trading below the adjusted conversion price of RMB 5.62 for 10 consecutive trading days, indicating potential for further price adjustments[21]. Expenses and Liabilities - Total operating costs decreased to CNY 344,671,152.58 from CNY 349,671,368.19[28]. - Research and development expenses rose to CNY 15,616,827.09, compared to CNY 14,635,763.55 in the prior period[28]. - Total liabilities increased to CNY 1,658,732,842.42 from CNY 1,627,081,011.90[26]. - The company incurred a total tax expense of CNY 5,102,492.16, compared to CNY 3,039,107.74 in the same quarter last year, representing an increase of approximately 67.8%[29]. - The company experienced a net cash outflow from investing activities of CNY 16,469,475.66, compared to a net outflow of CNY 18,245,973.24 in the previous year[33]. - The company reported a significant increase in investment losses, totaling CNY -5,718,305.64, compared to CNY -2,158,949.88 in Q1 2023[29].